These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33663779)

  • 1. Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II.
    Nazif TM; Moses J; Sharma R; Dhoble A; Rovin J; Brown D; Horwitz P; Makkar R; Stoler R; Forrest J; Messé S; Dickerman S; Brennan J; Zivadinov R; Dwyer MG; Lansky AJ;
    JACC Cardiovasc Interv; 2021 Mar; 14(5):515-527. PubMed ID: 33663779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Lansky AJ; Makkar R; Nazif T; Messé S; Forrest J; Sharma R; Schofer J; Linke A; Brown D; Dhoble A; Horwitz P; Zang M; DeMarco F; Rajagopal V; Dwyer MG; Zivadinov R; Stella P; Rovin J; Parise H; Kodali S; Baumbach A; Moses J
    Eur Heart J; 2021 Jul; 42(27):2670-2679. PubMed ID: 34000004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
    Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
    Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
    Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
    J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
    Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
    EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Cerebral Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis.
    Kaur A; Dhaliwal AS; Sohal S; Gwon Y; Gupta S; Bhatia K; Dominguez AC; Basman C; Tamis-Holland J
    J Am Heart Assoc; 2024 Feb; 13(3):e030587. PubMed ID: 38240252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Diffusion-Weighted Brain MRI Lesions After TAVR: Results of a Patient-Level Pooled Analysis.
    Lansky AJ; Grubman D; Dwyer MG; Zivadinov R; Parise H; Moses JW; Shah T; Pietras C; Tirziu D; Gambone L; Leon MB; Nazif TM; Messé SR
    J Am Coll Cardiol; 2024 Aug; 84(8):712-722. PubMed ID: 39142725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Giustino G; Mehran R; Veltkamp R; Faggioni M; Baber U; Dangas GD
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2124-2133. PubMed ID: 27765306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Difference in Post-procedural Stroke Rates Between Patients with Aortic Stenosis Who Undergo Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement.
    Burke H; Boron A; Lee JH; Kahlon KR
    Cureus; 2018 Apr; 10(4):e2494. PubMed ID: 29922535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Ndunda PM; Vindhyal MR; Muutu TM; Fanari Z
    Cardiovasc Revasc Med; 2020 Jun; 21(6):717-722. PubMed ID: 31175048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral protection devices during transcatheter aortic valve implantation.
    Vlastra W; Vendrik J; Koch KT; Baan J; Piek JJ; Delewi R
    Trends Cardiovasc Med; 2018 Aug; 28(6):412-418. PubMed ID: 29428159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
    Isogai T; Vanguru HR; Krishnaswamy A; Agrawal A; Spilias N; Shekhar S; Saad AM; Verma BR; Puri R; Reed GW; Popović ZB; Unai S; Yun JJ; Uchino K; Kapadia SR
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):810-820. PubMed ID: 35916117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.
    Haussig S; Mangner N; Dwyer MG; Lehmkuhl L; Lücke C; Woitek F; Holzhey DM; Mohr FW; Gutberlet M; Zivadinov R; Schuler G; Linke A
    JAMA; 2016 Aug; 316(6):592-601. PubMed ID: 27532914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Protection During Transcatheter Aortic Valve Implantation: An Updated Systematic Review and Meta-Analysis.
    Testa L; Latib A; Casenghi M; Gorla R; Colombo A; Bedogni F
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.
    Pagnesi M; Martino EA; Chiarito M; Mangieri A; Jabbour RJ; Van Mieghem NM; Kodali SK; Godino C; Landoni G; Colombo A; Latib A
    Int J Cardiol; 2016 Oct; 221():97-106. PubMed ID: 27400304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.